Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
SpringWorks Therapeutics (SWTX) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
$49.09M |
|
$-83.19M |
|
$3.53M |
|
$45.56M |
|
$129.62M |
|
$-80.54M |
|
$-2.65M |
|
$-83.19M |
|
$-83.19M |
|
$-83.19M |
|
$-83.19M |
|
$-83.19M |
|
$-83.19M |
|
$-80.54M |
|
$-79.44M |
|
74.89M |
|
74.89M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$356.32M |
|
$19.25M |
|
$149.04M |
|
$505.36M |
|
$82.27M |
|
-- |
|
$5.69M |
|
$87.96M |
|
$417.39M |
|
$417.39M |
|
$417.39M |
|
74.99M |
|
| Cash Flow Statement Financials | |
$-68.76M |
|
$73.39M |
|
$-10.61M |
|
$70.38M |
|
$64.40M |
|
$-5.97M |
|
$29.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.33 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
92.81% |
|
-164.07% |
|
-164.07% |
|
-- |
|
-169.47% |
|
-169.47% |
|
$-68.79M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.28 |
|
1.22 |
|
73.98 |
|
-19.93% |
|
-19.93% |
|
-16.46% |
|
-19.93% |
|
$5.57 |
|
$-0.92 |
|
$-0.92 |
|